Jinque Luo

Title: Jinque Luo: Innovator in Cardiovascular and Cerebrovascular Treatments

Introduction

Jinque Luo is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating cardiovascular and cerebrovascular diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Jinque Luo holds a patent for an indolo[2',3′:3,4]pyrido[2,1-b]quinazoline compound. This compound is represented by a general formula and has various applications in medicine. It can be used to manufacture a medicament for treating cardiovascular and cerebrovascular diseases. Additionally, it is involved in formulations that increase the expression of AMPK, ABCA1, and SR-BI. The compound also activates nuclear receptors while inhibiting the activity of NLRP3, IL-1β, NF-κB, and MAPKs. Furthermore, it promotes cellular cholesterol efflux and serves as a medicament for anti-inflammation.

Career Highlights

Jinque Luo is affiliated with the Chinese Academy of Medical Sciences, where he conducts research and develops innovative medical solutions. His work has garnered attention for its potential impact on treating serious health conditions. With a focus on advancing medical science, he continues to explore new avenues for therapeutic development.

Collaborations

Jinque Luo collaborates with esteemed colleagues, including Shuyi Si and Yanni Xu. These partnerships enhance the research environment and foster innovation in their respective fields.

Conclusion

Jinque Luo's contributions to medicinal chemistry and his innovative patent demonstrate his commitment to advancing healthcare solutions. His work has the potential to significantly impact the treatment of cardiovascular and cerebrovascular diseases.